Novel antibiotics to combat drug-resistant bacterial infections
Allecra Therapeutics has raised €37M across 2 funding rounds from 4 investors, most recently a Series B round in Jun 2016. Based in Weil am Rhein, Germany; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2016-06-01 | Series B | €22M | Delos Capital,Edmond de Rothschild Venture Capital,EMBL Ventures,Forbion Capital Partners | View deal → |
| 2015-04-01 | Series A | €15M | Edmond de Rothschild Venture Capital,EMBL Ventures | View deal → |
